Conexeu Sciences CEO Miles Harrison Highlights Tissue Regeneration Tech for GLP-1 Related Volume Loss, Eyes Early 2027 FDA Submission
During a fireside chat, Conexeu Sciences Inc. (Nasdaq: CNXU) CEO Miles Harrison discussed the company's preclinical-stage tissue regeneration technology, which aims to address large-volume tissue restoration. Harrison noted a growing demand for treatments to restore lost facial and body volume, driven by the widespread use of GLP-1 weight-loss drugs. The company anticipates an FDA 510(k) submission in early 2027 for its initial indication, with further plans to expand into dental and veterinary markets.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Samsung's Rainbow Robotics halts US robot shipments due to new American restrictions, plans to seek approval and US production
-
2
Posco International acquires US shale gas asset for $550 million
-
3
New Zealand's sovereign wealth fund has achieved a 14.2% annual return, ranking first globally, but its CEO warns that high returns in US equities are unsustainable.
-
4
Bitcoin corporate treasuries bought just 5.9K BTC in three months as holdings remained at unrealized loss
-
5
Ethereum founder Vitalik Buterin tweeted a comment on the ancient Chinese philosopher Mozi, calling his thought "proto d/acc."
-
6
Ethereum founder Vitalik Buterin: Qwen 3.8 Flash model's performance is impressive, local models are expected to handle a large number of tasks
-
7
AI boom tightens MLCC supply, giving Samsung Electro-Mechanics pricing power as it begins raising prices
-
8
Lookonchain monitoring shows Garrett Jin, the largest on-chain ZEC short, is now down over $26M, holding a $51.5M short position with a liquidation price of $2,631.53.
-
9
Microsoft AI Head Warns: Uncontrolled AI Could Lead to "Silicon Species" Competing with Humans, Criticizes Anthropic's Approach to AI
-
10
The 2026 Cryptocurrency Market: How to Identify High-Risk Altcoin Trading Platforms
Markets Today
Recommended Reading



